These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12744865)

  • 1. Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine.
    De Serres G; Boulianne N; Duval B; Rochette L; Grenier JL; Roussel R; Donaldson D; Tremblay M; Toth E; Ménard S; Landry M; Robert Y
    Vaccine; 2003 Jun; 21(19-20):2346-53. PubMed ID: 12744865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.
    De Serres G; Toth E; Ménard S; Grenier JL; Roussel R; Tremblay M; Landry M; Robert Y; Rochette L; Skowronski DM
    Vaccine; 2005 May; 23(28):3726-32. PubMed ID: 15882534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination.
    De Serres G; Grenier JL; Toth E; Ménard S; Roussel R; Tremblay M; Fradet MD; Landry M; Robert Y; Skowronski DM
    Vaccine; 2003 Jun; 21(19-20):2354-61. PubMed ID: 12744866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination.
    Grenier JL; Toth E; De Serres G; Ménard S; Roussel R; Tremblay M; Landry M; Robert Y; Skowronski DM
    Can Commun Dis Rep; 2004 Jan; 30(2):9-16. PubMed ID: 14964915
    [No Abstract]   [Full Text] [Related]  

  • 5. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?
    Skowronski DM; Strauss B; De Serres G; MacDonald D; Marion SA; Naus M; Patrick DM; Kendall P
    Clin Infect Dis; 2003 Mar; 36(6):705-13. PubMed ID: 12627354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
    De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
    Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk of recurrence of oculorespiratory syndrome following influenza revaccination.
    Skowronski DM; Strauss B; Kendall P; Duval B; De Serres G
    CMAJ; 2002 Oct; 167(8):853-8. PubMed ID: 12406942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculorespiratory syndrome after influenza immunization in children.
    Skowronski DM; Bjornson G; Husain E; Metzger DL; Scheifele DW
    Pediatr Infect Dis J; 2005 Jan; 24(1):63-9. PubMed ID: 15665712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary Statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination.
    National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2001 Nov; 27():1-7. PubMed ID: 11817153
    [No Abstract]   [Full Text] [Related]  

  • 10. Supplementary statement for the 2002-2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination.
    Orr P
    Can Commun Dis Rep; 2002 Sep; 28(ACS-6):1. PubMed ID: 12219587
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.
    Skowronski DM; De Serres G; Hebert J; Stark D; Warrington R; Macnabb J; Shadmani R; Rochette L; MacDonald D; Patrick DM; Duval B
    Vaccine; 2002 Jun; 20(21-22):2713-9. PubMed ID: 12034097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.
    Can Commun Dis Rep; 2005 Nov; 31(21):217-25. PubMed ID: 16669126
    [No Abstract]   [Full Text] [Related]  

  • 13. ORS during the 2000-2001 influenza vaccination season.
    Choudhri Y; Walop W; Squires S; Tam T; King A; Skowronski D; Warrington R; Wood J
    Can Commun Dis Rep; 2002 Sep; 28(ACS-6):2-8. PubMed ID: 12219588
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination--Quebec, 2000.
    Boulianne N; De Serres G; Duval B; Shadmani R; Rochette L
    Can Commun Dis Rep; 2001 May; 27(10):85-90. PubMed ID: 11396047
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.
    Skowronski DM; De Serres G; Scheifele D; Russell ML; Warrington R; Davies HD; Dionne M; Duval B; Kellner J; MacDonald J
    Clin Infect Dis; 2003 Oct; 37(8):1059-66. PubMed ID: 14523770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.
    Scheifele DW; Duval B; Russell ML; Warrington R; DeSerres G; Skowronski DM; Dionne M; Kellner J; Davies D; MacDonald J
    Clin Infect Dis; 2003 Apr; 36(7):850-7. PubMed ID: 12652385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?
    Skowronski DM; Lu H; Warrington R; Hegele RG; De Serres G; HayGlass K; Stark D; White R; Macnabb J; Li Y; Manson HE; Brunham RC
    J Infect Dis; 2003 Feb; 187(3):495-9. PubMed ID: 12552434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.
    Al-Dabbagh M; Lapphra K; Scheifele DW; Halperin SA; Langley JM; Cho P; Kollmann TR; Li Y; De Serres G; Fortuno ES; Bettinger JA
    Clin Vaccine Immunol; 2013 Aug; 20(8):1108-14. PubMed ID: 23697573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination.
    Fredette MJ; De Serres G; Malenfant M
    Clin Infect Dis; 2003 Oct; 37(8):1136-8. PubMed ID: 14523781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.